GSK2850163 S enantiomer is primarily investigated for its potential therapeutic applications in medical research, particularly in the treatment of inflammatory diseases. Its mechanism of action involves targeting specific pathways that regulate inflammation, making it a promising candidate for conditions such as rheumatoid arthritis, psoriasis, and other autoimmune disorders. Researchers are exploring its efficacy in preclinical studies to assess its ability to modulate immune responses and reduce inflammatory markers. Additionally, its S enantiomer form is studied for its improved pharmacological properties, such as enhanced binding affinity and reduced side effects, compared to its racemic mixture. This compound is also being evaluated for its potential use in combination therapies to enhance treatment outcomes for chronic inflammatory conditions.